Endocrine side effects during cancer treatment. Lecture for practitioners
Targeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy a...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ZAO "Consilium Medicum"
2022-08-01
|
Series: | Consilium Medicum |
Subjects: | |
Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128 |
_version_ | 1811320494471774208 |
---|---|
author | Anastasiya A. Glibka Natalya V. Mazurina Ekaterina A. Troshina |
author_facet | Anastasiya A. Glibka Natalya V. Mazurina Ekaterina A. Troshina |
author_sort | Anastasiya A. Glibka |
collection | DOAJ |
description | Targeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy and emergency situations for each endocrinopathy, i.e. hyperglycemia during treatment with alpelisib and destructive thyroiditis and hypophysitis during treatment of ICI. |
first_indexed | 2024-04-13T13:00:31Z |
format | Article |
id | doaj.art-60f253993f974061b36db8b0df1419b4 |
institution | Directory Open Access Journal |
issn | 2075-1753 2542-2170 |
language | Russian |
last_indexed | 2024-04-13T13:00:31Z |
publishDate | 2022-08-01 |
publisher | ZAO "Consilium Medicum" |
record_format | Article |
series | Consilium Medicum |
spelling | doaj.art-60f253993f974061b36db8b0df1419b42022-12-22T02:45:55ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702022-08-0124641642110.26442/20751753.2022.6.2016954568Endocrine side effects during cancer treatment. Lecture for practitionersAnastasiya A. Glibka0https://orcid.org/0000-0002-7324-8344Natalya V. Mazurina1https://orcid.org/0000-0001-8077-9381Ekaterina A. Troshina2https://orcid.org/0000-0002-8520-8702Endocrinology Research CentreEndocrinology Research CentreEndocrinology Research CentreTargeted therapy and immune checkpoint inhibitors (ICI) are increasingly being used to treat many solid tumors. The use alpelisib and ICPI has a risk of side-effects, particularly endocrine dysfunctions. In this lecture, there are clearly stated: initial screening, monitoring, selection of therapy and emergency situations for each endocrinopathy, i.e. hyperglycemia during treatment with alpelisib and destructive thyroiditis and hypophysitis during treatment of ICI.https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128hyperglycemiadestructive thyroiditishypophysitisalpelisibimmune checkpoint inhibitors |
spellingShingle | Anastasiya A. Glibka Natalya V. Mazurina Ekaterina A. Troshina Endocrine side effects during cancer treatment. Lecture for practitioners Consilium Medicum hyperglycemia destructive thyroiditis hypophysitis alpelisib immune checkpoint inhibitors |
title | Endocrine side effects during cancer treatment. Lecture for practitioners |
title_full | Endocrine side effects during cancer treatment. Lecture for practitioners |
title_fullStr | Endocrine side effects during cancer treatment. Lecture for practitioners |
title_full_unstemmed | Endocrine side effects during cancer treatment. Lecture for practitioners |
title_short | Endocrine side effects during cancer treatment. Lecture for practitioners |
title_sort | endocrine side effects during cancer treatment lecture for practitioners |
topic | hyperglycemia destructive thyroiditis hypophysitis alpelisib immune checkpoint inhibitors |
url | https://consilium.orscience.ru/2075-1753/article/viewFile/109885/84128 |
work_keys_str_mv | AT anastasiyaaglibka endocrinesideeffectsduringcancertreatmentlectureforpractitioners AT natalyavmazurina endocrinesideeffectsduringcancertreatmentlectureforpractitioners AT ekaterinaatroshina endocrinesideeffectsduringcancertreatmentlectureforpractitioners |